HanesBrands of New York City announced on July 24 it paid about $575 million for Maidenform in Iselin. Both are clothing distributors.
Quest Sells Drug Royalty Rights
Diagnostic information provider Quest Diagnostics in Madison announced on July 18 the $485 million sale of its rights to royalties from experimental cancer drug ibrutinib to Royalty Pharma of New York City, an acquirer of biopharmaceutical royalty interests.
Gain Capital Unit Acquired
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
